Onera

Overview

Onera Health develops patch-based, wireless polysomnography (PSG) systems for at-home sleep diagnostics, providing clinical-grade monitoring of cardiovascular, respiratory, and brain functions.¹⁴⁶ The company targets sleep disorders like insomnia, sleep apnea, and narcolepsy, offering user-friendly alternatives to traditional sleep lab tests through hardware patches and cloud-based analytics.²³ It operates as a med-tech firm in the sleep medicine market, generating revenue from device sales and data services, with backing from investors including Gimv and EQT.¹⁵

History

Onera Health was founded in 2017 in Eindhoven, Netherlands, as a spin-off from the imec research center by Ruben de Francisco, who serves as CEO.¹⁶ The company has leveraged imec's technology to develop its no-wire PSG patch system for home use.¹² Key milestones include securing Series C financing to expand manufacturing and sales, supported by investors like Gimv and EQT.¹⁵

Product Lines

Manufacturing

Manufacturing is accelerated through Series C funding to meet demand for the self-applied, no-wire patch system.¹ Production leverages technology from the imec research center spin-off, with no specific details on in-house versus outsourced facilities.¹⁶

Notable Products

• Onera Sleep Test System (STS) - Patch-based, wireless PSG sensor capturing multiple physiological signals for home or clinical use.
• Onera Digital Health Platform - Cloud platform for PSG data analysis, diagnostics, and treatment monitoring.

Reputation

Onera Health is recognized by investors and med-tech analysts for disrupting sleep diagnostics with convenient, accurate at-home PSG solutions that reduce hospital backlogs.¹² Professionals value its clinical-grade reliability stemming from imec technology and user-centric design.¹⁶ Limited public data on widespread user feedback, though funding from EQT and Gimv signals strong industry confidence.¹⁵